FDA Clears Luminex's Gastrointestinal Pathogen Assay | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared Luminex's xTAG Gastrointestinal Pathogen Panel for marketing in the US, Luminex announced today.

The assay is cleared to run on the Luminex 100/200 system, and Luminex said that it is "the first comprehensive molecular diagnostic assay that tests more than 90 percent of bacterial, viral, and parasitic causes of infectious gastroenteritis in a single assay."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.